---
title: "Surgery for operable breast cancer after neoadjuvant chemotherapy"
slug: "surgery-for-operable-breast-cancer-after-neoadjuvant-chemotherapy"
date: "2023-10-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Clinical Pathway-of-breast cancer]]

# Surgery for operable breast cancer after neoadjuvant chemotherapy

> ğŸ†•ğŸ§ª â†’ ğŸ”ª

- Operable breast cancer preferred for neoadjuvant(ç‰›é˜¿ç ) chemotherapy are
  - cT2N0 or cT2N1(only 1 or 2 nodes)
  - HER2-é™½ breast cancer(preferable) or TNBC ä¸‰é™°
  - Larger primary tumor relative to breast size in patients who desire BCS
      - éƒ½é‚£éº¼å¤§äº†é‚„è¦ç•™ï¼Ÿè¡Œï¼Œç‰›é˜¿ç 
- [[clips placement]] both at â†£ primary tumor and positive axillary lymph node(s),Surgery after Chemotherapy
  - [[BCS]]/Mastectomy
- Axillary management:
    - If cN0 both before and after C/T â†’ SLNB
    - If cN1 become ycN0 after C/T, may consider SLNB + clipped node removal
    - If cN2 or 3 before C/T â†’ [[ALND]]
